Covid-19 - Pharmaceutical Technology https://www.pharmaceutical-technology.com/sector/theme/macro/covid-19/ The leading site for news and procurement in the pharmaceutical industry Wed, 17 Apr 2024 10:28:02 +0000 en-US hourly 1 https://wordpress.org/?v=6.4.2 https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2022/01/cropped-Pharmaceutical-Technology-Favicon-150x150.png Covid-19 - Pharmaceutical Technology https://www.pharmaceutical-technology.com/sector/theme/macro/covid-19/ 32 32 Johnson & Johnson reports net earnings of $5.3bn in Q1 2024 https://www.pharmaceutical-technology.com/news/johnson-johnson-earnings-q1-2024/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/Johnson-Johnson.jpg Wed, 17 Apr 2024 10:09:49 +0000 https://www.pharmaceutical-technology.com/news/johnson-johnson-earnings-q1-2024/ Q&A: BARDA wants to back tech that can combat multiple infections, says director https://www.pharmaceutical-technology.com/interviews/qa-barda-chief-says-agency-looks-to-back-tech-that-can-combat-multiple-infections/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/04/shutterstock_1674044449-scaled.jpg Fri, 05 Apr 2024 07:42:56 +0000 https://www.pharmaceutical-technology.com/interviews/qa-barda-chief-says-agency-looks-to-back-tech-that-can-combat-multiple-infections/ Merck reports drop in net income for fiscal 2023 https://www.pharmaceutical-technology.com/news/merck-net-income-2023/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/03/merck.jpg Thu, 07 Mar 2024 10:49:54 +0000 https://www.pharmaceutical-technology.com/news/merck-net-income-2023/ Moderna reports net loss of $4.7bn for full year 2023 https://www.pharmaceutical-technology.com/news/moderna-net-loss-full-year-2023/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/02/Moderna.jpg Fri, 23 Feb 2024 10:38:02 +0000 https://www.pharmaceutical-technology.com/news/moderna-net-loss-full-year-2023/ Everest ends Covid-19 mRNA vaccine deal with Providence https://www.pharmaceutical-technology.com/news/everest-ends-covid-19-mrna-vaccine-deal-with-providence/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/02/shutterstock_162854627.jpg Tue, 20 Feb 2024 18:48:42 +0000 https://www.pharmaceutical-technology.com/news/everest-ends-covid-19-mrna-vaccine-deal-with-providence/ MHRA agrees licence change for Pfizer-BioNTech’s Comirnaty vaccine https://www.pharmaceutical-technology.com/news/mhra-licence-pfizer-biontech-vaccine/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/02/MHRA.jpg Mon, 12 Feb 2024 10:18:59 +0000 https://www.pharmaceutical-technology.com/news/mhra-licence-pfizer-biontech-vaccine/ AstraZeneca posts 81% rise in FY 2023 profit after tax https://www.pharmaceutical-technology.com/news/astrazeneca-fy-2023-profit-after-tax/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/02/AZ.jpg Fri, 09 Feb 2024 08:11:43 +0000 https://www.pharmaceutical-technology.com/news/astrazeneca-fy-2023-profit-after-tax/ VGXI’s New Headquarters and Manufacturing Facility, Conroe, Texas https://www.pharmaceutical-technology.com/projects/vgxi-headquarters-manufacturing-facility-conroe/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2021/11/Featured-Image-VGXIs-New-Headquarters-and-Manufacturing-Facility-Conroe-Texas.jpg Fri, 26 Jan 2024 13:49:47 +0000 https://www.pharmaceutical-technology.com/?post_type=projects&p=143493 What is the UK’s Covid-19 drug armoury like amid rising infection levels? https://www.pharmaceutical-technology.com/news/what-is-the-uks-covid-19-drug-armoury-like-amid-rising-infection-levels/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/shutterstock_1870297000.jpg Thu, 25 Jan 2024 14:03:21 +0000 https://www.pharmaceutical-technology.com/news/what-is-the-uks-covid-19-drug-armoury-like-amid-rising-infection-levels/ HHS reiterates plans to allow Paxlovid access regardless of insurance   https://www.pharmaceutical-technology.com/news/hhs-reiterates-plans-to-allow-paxlovid-access-regardless-of-insurance/ https://www.pharmaceutical-technology.com/wp-content/uploads/sites/24/2024/01/shutterstock_2071222616-e1706111589295.jpg Wed, 24 Jan 2024 16:30:11 +0000 https://www.pharmaceutical-technology.com/news/hhs-reiterates-plans-to-allow-paxlovid-access-regardless-of-insurance/